Pegylated Recombinant Mammalian Uricase (PEG-uricase) as Treatment for Refractory Gout
Clinical trial NCT00111657 · COMPLETED
Trial details
- NCT number
- NCT00111657
- Sponsor
- John Sundy
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-12-01
- Primary completion
- 2009-07-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.